ANZ-521

· Anza Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANZ-521, covering 2009-02-20 to 2009-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus [Phase 1, Phase 2]

See pricing